Back Login to subscribe 🔔 Set Alert

BRTX BioRestorative Therapies, Inc. Common Stock (NV)

15 min delay

Loading...

Loading...

Loading...

Loading options…

CALLS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

PUTS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

Loading insider data…

Date	Headline	Sentiment
	12 Health Care Stocks Moving In Thursday's After-Market Session	96.55%
	12 Health Care Stocks Moving In Thursday's Pre-Market Session	96.77%
	12 Health Care Stocks Moving In Wednesday's Intraday Session	96.57%
	BioRestorative Therapies shares are trading higher after Kaos Capital announced that it has acquired 4.9% of the issued and outstanding common stock of BioRestorative Therapies.	95.09%
	Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results	97.07%
	Kaos Capital Acquires 4.9% Of Issued And Outstanding Common Stock Of BioRestorative Therapies; Terms Undisclosed	69.8%
	BioRestorative Therapies Doses Last Participant In Its Phase 2 Clinical Study Of BRTX-100 To Treat Chronic Lumbar Disc Disease	74.79%
	12 Health Care Stocks Moving In Tuesday's After-Market Session	91.05%
	BioRestorative Therapies Presents Data Showing MSC-Derived Exosomes Have Source-Specific Functional Signatures For Targeted Therapeutic Applications At The International Society For Cell & Gene Therapy 2026 Annual Meeting	92.06%
	BioRestorative Therapies Reports 52% Of Phase 2 Patients Achieve At Least 50% Pain And Function Improvement At 52 Weeks With No Dose-Limiting Toxicity In ISCT 2026 Update	82.48%